10.30.26 -- Implementing AI Solutions In GMP While Managing Risk

CAR-T therapies now make up 73% of active pipeline programs, yet solid tumors remain largely out of reach. Where is T cell immunotherapy headed next, and what does it mean for your pipeline strategy?

View automated, high‑throughput BiTE screening in mammalian cells, enabling rapid discovery of efficacious variants through precise genomic integration and scalable workflows.

A practical checklist covering the key CMC modules required for first-in-human CTD submissions, with guidance on characterization, manufacturing controls, stability, and patient safety documentation.

Transition from periodic sampling to continuous monitoring. Learn to establish risk-based alert limits and use N:M trending to maintain a true state of control in critical cleanroom zones.

Combine quantitative enzyme indicators, computational fluid dynamics, and traditional biological indicators to improve VPHP isolator validation and process confidence.

Sensitive digital PCR methods enable confident detection of low‑abundance iPSC markers. Gain insight into how these capabilities support more reliable monitoring and quality assessment.

High refolding yields aren’t enough. See how analytical characterization, structural equivalence testing, and optimized fermentation reduce scale-up risk and improve quality.

A multi-stage filtration approach reduces microbial load, protects critical filters, and helps ensure consistent product quality, process reliability, and patient safety in biopharmaceutical manufacturing.

Rigorous multi-cycle stress testing and environmental validation ensure manufacturing hardware delivers uncompromising reliability for critical processing workflows.

Discover a practical roadmap for replacing animal tests with advanced molecular methods, as well as how regulatory updates and innovative technologies are shaping a sustainable future.

Capturing dynamic biomolecular motion remains crucial for research. EPR spectroscopy delivers ensemble distance distributions to resolve flexible states in complex protein systems.

Examine how connected, purpose-built systems help quality, IT, and operations teams improve collaboration while maintaining compliance across every integration. 

Complex biologics need scalable, GMP-ready development from the start. Early decisions, scientific continuity, and strong partnerships help reduce delays and rework.

Early risk identification is critical to predictable technology transfer. Uncover how data-driven modeling, multivariate analysis, and proactive collaboration help keep manufacturing timelines on track.

Read about how focused optimization and coordinated execution helped overcome technical uncertainty and enable faster progression to market readiness.

Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

Review how Agentic AI sharpens batch release workflows by surfacing faster insights, reducing manual effort, and giving teams clearer oversight. It offers a more organized and compliant route.